Ginsenoside B2

Star0

DB14815InvestigationalSmall molecule

Ginsenoside B2 is under investigation in clinical trial NCT00781534 (A Clinical Trial of Ginseng in Diabetes).

Mechanism: Pharmacologically active on Estrogen receptor, Androgen receptor, and Progesterone receptor
Curator reviewed
Formula / weight: C₄₈H₈₂O₁₈ · 947.166 g/mol (avg)
Also known as: Ginsenoside Re

Resolves to

Compound

UNII46F3R0BL3ICAS52286-59-6ChEMBLCHEMBL510095ChEBI77148KEGGC08944

Structure

InChIKeyPWAOOJDMFUQOKB-WCZZMFLVSA-NSMILES

[H][C@@]1(CC[C@]2(C)[C@]1([H])[C@H](O)C[C@]1([H])[C@@]3(C)CC[C@H](O)C(C)(C)[C@]3([H])[C@H](C[C@@]21C)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O)C(C)(CCC=C(C)C)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O

Targets

P03372ESR1P10275AR P06401PGR

What you can answer from here — as of July 07, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Ginsenoside B2, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account